lansoprazole has been researched along with Vascular Calcification in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Vascular Calcification: Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, T | 1 |
| Hatakeyama, S | 1 |
| Hosogoe, S | 1 |
| Tanaka, Y | 1 |
| Imanishi, K | 1 |
| Takashima, T | 1 |
| Saitoh, F | 1 |
| Suzuki, T | 1 |
| Ohyama, C | 1 |
| Kiffer-Moreira, T | 1 |
| Yadav, MC | 1 |
| Zhu, D | 1 |
| Narisawa, S | 1 |
| Sheen, C | 1 |
| Stec, B | 1 |
| Cosford, ND | 1 |
| Dahl, R | 1 |
| Farquharson, C | 1 |
| Hoylaerts, MF | 1 |
| Macrae, VE | 1 |
| Millán, JL | 1 |
2 other studies available for lansoprazole and Vascular Calcification
| Article | Year |
|---|---|
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Topics: Aged; Aorta, Abdominal; Computed Tomography Angiography; Disease Progression; Esomeprazole; Female; | 2018 |
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alkaline Phosphatase; Animals; Calcification, Physiologic; | 2013 |